Ricerc@Sapienza

Particle Therapy (PT) is a non-invasive technique that exploits charged light ions for the irradiation of tumours that cannot be effectively treated with surgery or conventional radiotherapy. While the largest dose fraction is released to the tumour volume by the primary beam, a non-negligible amount of additional dose is due to the beam fragmentation that occurs along the path towards the target volume.

Particle Therapy (PT) is a radiation therapy technique in which solid tumors are treated with charged ions and exploits the achievable highly localized dose delivery, allowing to spare healthy tissues and organs at risk. The development of a range monitoring technique to be used on-line, during the treatment, capable to reach millimetric precision is considered one of the important steps towards an optimization of the PT efficacy and of the treatment quality.

The advanced lead fast reactor European demonstrator (ALFRED) is a European research initiative into the framework of the Generation IV International Forum facilities. ALFRED is a scaled down reactor compared to the industrial prototype European lead fast reactor proposed in lead-cooled European advanced demonstration reactor. It has a relatively low power (125 MWe) with a compact design to reduce the cost but maintaining its representativeness and it is cooled by pure lead.

During Particle Therapy treatments the patient irradiation produces, among different types of secondary radiation, an abundant flux of neutrons that can release a significant dose far away from the tumour region. A precise measurement of their flux, energy and angle distributions is eagerly needed in order to improve the Treatment Planning Systems software and to properly take into account the risk of late complications in the whole body.